Fig. 5From: Role of fused PET/CT compared to the standard contrast-enhanced CT in the follow-up assessment of the treated gastric malignancyAxial and coronal post-contrast CT, PET, and fused PET/CT images for a 52-year-female patient with gastric neoplasm; she had received chemotherapy. Images a–c showed no metabolically active residual/recurrent gastric lesions (yellow arrows). Images d–f showed no metabolically active nodal or metastatic lesionsBack to article page